Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses
COVID vaccines averted infection in 10% of patient-facing healthcare staff during second wave
20 July 2022Smoke without fire? Researchers question heated tobacco products
21 July 2022Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today, found protection in older adults aged over 65 years, and in clinically vulnerable adults.
